Compare Abbott Laboratories (ABT) vs Packaging Corporation of America (PKG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Packaging Corporation of America — how do they compare? Abbott Laboratories trades at $95.83 (market cap $166.94B), while Packaging Corporation of America trades at $224.44 (market cap $20.71B). The key difference: Abbott Laboratories is far larger — about 8.1× Packaging Corporation of America's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | PKG | |
|---|---|---|
Market Cap | $166.94B | $20.71B |
Sector | Health | Technology |
52-Week High | $136.62 | $246.31 |
52-Week Low | $82.57 | $191.41 |
Enterprise Value | $193.69B | $24.53B |
Dividend Yield | 2.63% | 2.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Packaging Corporation of America (PKG) trades at $236.39, down 0.76% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported a Q1 2026 EPS beat of $2.40 versus $2.14 expected, with revenue growth to $2.4 billion. Recent news highlights a 20% dividend increase to an annual $6.00 per share and upcoming Q2 2026 earnings call on July 23, 2026.
PKG presents a mixed outlook with strong profitability metrics like a 16.21% ROE and 8.04% net margin, but faces margin pressure and two recent earnings misses. The consensus price target of $245 suggests modest upside, though risks include input cost inflation and competitive pressures. Institutional sentiment is cautiously optimistic with 38% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
